159 related articles for article (PubMed ID: 32329836)
1. CDKN3 regulates cisplatin resistance to colorectal cancer through TIPE1.
Li WH; Zhang L; Wu YH
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3614-3623. PubMed ID: 32329836
[TBL] [Abstract][Full Text] [Related]
2. TNFAIP8 regulates cisplatin resistance through TAF-Iα and promotes malignant progression of esophageal cancer.
Zhang DL; Yang N
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4775-4784. PubMed ID: 32432789
[TBL] [Abstract][Full Text] [Related]
3. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
Dai W; Miao H; Fang S; Fang T; Chen N; Li M
Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
Wang H; Chen H; Zhou H; Yu W; Lu Z
Oncol Res; 2017 Nov; 25(9):1431-1440. PubMed ID: 28109073
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies of cyclin-dependent kinase inhibitor 3 (CDKN3) in colorectal cancer.
Yang C; Sun JJ
Asian Pac J Cancer Prev; 2015; 16(3):965-70. PubMed ID: 25735390
[TBL] [Abstract][Full Text] [Related]
6. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.
Zhang LP; Li WJ; Zhu YF; Huang SY; Fang SY; Shen L; Gao YL
Int J Clin Exp Pathol; 2015; 8(5):4535-44. PubMed ID: 26191143
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
[TBL] [Abstract][Full Text] [Related]
8. The role of cyclin-dependent kinase inhibitor 3 in the proliferation and migration of renal cell carcinoma.
Ni C; Guo Z; Bu H; Zhao X; Bao M; Ding L; Liang C; Tang Q; Li J
Chem Biol Interact; 2024 Jul; 397():111092. PubMed ID: 38825053
[TBL] [Abstract][Full Text] [Related]
9. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
10. CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.
Barrón EV; Roman-Bassaure E; Sánchez-Sandoval AL; Espinosa AM; Guardado-Estrada M; Medina I; Juárez E; Alfaro A; Bermúdez M; Zamora R; García-Ruiz C; Gomora JC; Kofman S; Pérez-Armendariz EM; Berumen J
PLoS One; 2015; 10(9):e0137397. PubMed ID: 26372210
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.
Li Y; Ji S; Fu LY; Jiang T; Wu D; Meng FD
Oncol Res; 2017 May; 25(5):721-731. PubMed ID: 27983933
[TBL] [Abstract][Full Text] [Related]
12. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
Li T; Xue H; Guo Y; Guo K
Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
[TBL] [Abstract][Full Text] [Related]
13. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
14. LAMP2A regulates cisplatin resistance in colorectal cancer through mediating autophagy.
Shi Z; Yang S; Shen C; Shao J; Zhou F; Liu H; Zhou G
J Cancer Res Clin Oncol; 2024 May; 150(5):242. PubMed ID: 38717639
[TBL] [Abstract][Full Text] [Related]
15. Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
Deng M; Wang J; Chen Y; Zhang L; Xie G; Liu Q; Zhang T; Yuan P; Liu D
Mol Med Rep; 2016 Aug; 14(2):1523-30. PubMed ID: 27314680
[TBL] [Abstract][Full Text] [Related]
16. GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis.
Deng X; Ma J; Zhou W; Yuan Y; Wang B; Meng X
Lab Invest; 2023 Jun; 103(6):100122. PubMed ID: 36828188
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
18. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
Chen K; Abuduwufuer A; Zhang H; Luo L; Suotesiyali M; Zou Y
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6935-6943. PubMed ID: 31486493
[TBL] [Abstract][Full Text] [Related]
19. DCLK1 promotes malignant progression of breast cancer by regulating Wnt/β-Catenin signaling pathway.
Wang YL; Li Y; Ma YG; Wu WY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9489-9498. PubMed ID: 31773701
[TBL] [Abstract][Full Text] [Related]
20. Circ-0104631 promotes cell proliferation and invasion in colorectal cancer and predicts poor prognosis.
Cao JZ; Ma LM; Zhang YL; Guo HC; Niu X; Zhao TB
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4730-4737. PubMed ID: 31210299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
